nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminoglutethimide—CYP1A2—Carmustine—brain cancer	0.254	0.351	CbGbCtD
Aminoglutethimide—CYP3A4—Temozolomide—brain cancer	0.192	0.265	CbGbCtD
Aminoglutethimide—CYP3A4—Lomustine—brain cancer	0.163	0.225	CbGbCtD
Aminoglutethimide—CYP1A2—Etoposide—brain cancer	0.0754	0.104	CbGbCtD
Aminoglutethimide—CYP3A4—Etoposide—brain cancer	0.0395	0.0545	CbGbCtD
Aminoglutethimide—Hepatotoxicity—Lomustine—brain cancer	0.0118	0.0639	CcSEcCtD
Aminoglutethimide—CYP11A1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.009	0.099	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00624	0.0686	CbGpPWpGaD
Aminoglutethimide—Hepatotoxicity—Hydroxyurea—brain cancer	0.00578	0.0314	CcSEcCtD
Aminoglutethimide—Pancytopenia—Lomustine—brain cancer	0.00541	0.0294	CcSEcCtD
Aminoglutethimide—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00478	0.0526	CbGpPWpGaD
Aminoglutethimide—Hepatotoxicity—Carmustine—brain cancer	0.00467	0.0254	CcSEcCtD
Aminoglutethimide—Haemolytic anaemia—Procarbazine—brain cancer	0.00464	0.0252	CcSEcCtD
Aminoglutethimide—Hepatotoxicity—Temozolomide—brain cancer	0.00452	0.0245	CcSEcCtD
Aminoglutethimide—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00435	0.0479	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00373	0.041	CbGpPWpGaD
Aminoglutethimide—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00371	0.0408	CbGpPWpGaD
Aminoglutethimide—Hepatotoxicity—Etoposide—brain cancer	0.00361	0.0196	CcSEcCtD
Aminoglutethimide—Leukopenia—Lomustine—brain cancer	0.00356	0.0193	CcSEcCtD
Aminoglutethimide—Pancytopenia—Procarbazine—brain cancer	0.00344	0.0187	CcSEcCtD
Aminoglutethimide—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00339	0.0373	CbGpPWpGaD
Aminoglutethimide—Drowsiness—Procarbazine—brain cancer	0.00323	0.0175	CcSEcCtD
Aminoglutethimide—Anorexia—Lomustine—brain cancer	0.00309	0.0168	CcSEcCtD
Aminoglutethimide—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00297	0.0327	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00293	0.0322	CbGpPWpGaD
Aminoglutethimide—Body temperature increased—Carboplatin—brain cancer	0.00293	0.0159	CcSEcCtD
Aminoglutethimide—Decreased appetite—Lomustine—brain cancer	0.00282	0.0153	CcSEcCtD
Aminoglutethimide—Pancytopenia—Hydroxyurea—brain cancer	0.00266	0.0144	CcSEcCtD
Aminoglutethimide—Neutropenia—Hydroxyurea—brain cancer	0.00262	0.0142	CcSEcCtD
Aminoglutethimide—Body temperature increased—Lomustine—brain cancer	0.00256	0.0139	CcSEcCtD
Aminoglutethimide—Drowsiness—Hydroxyurea—brain cancer	0.0025	0.0136	CcSEcCtD
Aminoglutethimide—CYP11A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00241	0.0265	CbGpPWpGaD
Aminoglutethimide—Anaemia—Procarbazine—brain cancer	0.00233	0.0127	CcSEcCtD
Aminoglutethimide—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.0023	0.0253	CbGpPWpGaD
Aminoglutethimide—Leukopenia—Procarbazine—brain cancer	0.00226	0.0123	CcSEcCtD
Aminoglutethimide—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.00221	0.0243	CbGpPWpGaD
Aminoglutethimide—Pancytopenia—Carmustine—brain cancer	0.00215	0.0117	CcSEcCtD
Aminoglutethimide—Myalgia—Procarbazine—brain cancer	0.00215	0.0117	CcSEcCtD
Aminoglutethimide—Neutropenia—Carmustine—brain cancer	0.00212	0.0115	CcSEcCtD
Aminoglutethimide—Pancytopenia—Temozolomide—brain cancer	0.00208	0.0113	CcSEcCtD
Aminoglutethimide—Vomiting—Lomustine—brain cancer	0.00206	0.0112	CcSEcCtD
Aminoglutethimide—Neutropenia—Temozolomide—brain cancer	0.00205	0.0111	CcSEcCtD
Aminoglutethimide—Tachycardia—Procarbazine—brain cancer	0.00201	0.0109	CcSEcCtD
Aminoglutethimide—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00197	0.0216	CbGpPWpGaD
Aminoglutethimide—Anorexia—Procarbazine—brain cancer	0.00196	0.0107	CcSEcCtD
Aminoglutethimide—CYP19A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00194	0.0214	CbGpPWpGaD
Aminoglutethimide—Nausea—Lomustine—brain cancer	0.00193	0.0105	CcSEcCtD
Aminoglutethimide—Hypotension—Procarbazine—brain cancer	0.00192	0.0104	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00187	0.0102	CcSEcCtD
Aminoglutethimide—Somnolence—Procarbazine—brain cancer	0.00183	0.00993	CcSEcCtD
Aminoglutethimide—Anaemia—Hydroxyurea—brain cancer	0.0018	0.00979	CcSEcCtD
Aminoglutethimide—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.00179	0.0197	CbGpPWpGaD
Aminoglutethimide—Decreased appetite—Procarbazine—brain cancer	0.00179	0.00971	CcSEcCtD
Aminoglutethimide—Leukopenia—Hydroxyurea—brain cancer	0.00175	0.00948	CcSEcCtD
Aminoglutethimide—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.00172	0.019	CbGpPWpGaD
Aminoglutethimide—Pancytopenia—Etoposide—brain cancer	0.00166	0.00903	CcSEcCtD
Aminoglutethimide—Neutropenia—Etoposide—brain cancer	0.00164	0.00889	CcSEcCtD
Aminoglutethimide—Urticaria—Procarbazine—brain cancer	0.00163	0.00888	CcSEcCtD
Aminoglutethimide—Body temperature increased—Procarbazine—brain cancer	0.00163	0.00883	CcSEcCtD
Aminoglutethimide—CYP19A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00159	0.0175	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00158	0.0174	CbGpPWpGaD
Aminoglutethimide—Anorexia—Hydroxyurea—brain cancer	0.00152	0.00824	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Procarbazine—brain cancer	0.00152	0.00823	CcSEcCtD
Aminoglutethimide—CYP19A1—Ovarian Infertility Genes—ESR2—brain cancer	0.0015	0.0165	CbGpPWpGaD
Aminoglutethimide—Anaemia—Carmustine—brain cancer	0.00146	0.00792	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Etoposide—brain cancer	0.00146	0.00791	CcSEcCtD
Aminoglutethimide—Pruritus—Procarbazine—brain cancer	0.00146	0.0079	CcSEcCtD
Aminoglutethimide—Somnolence—Hydroxyurea—brain cancer	0.00142	0.00769	CcSEcCtD
Aminoglutethimide—Leukopenia—Carmustine—brain cancer	0.00141	0.00767	CcSEcCtD
Aminoglutethimide—Anaemia—Temozolomide—brain cancer	0.00141	0.00765	CcSEcCtD
Aminoglutethimide—Decreased appetite—Hydroxyurea—brain cancer	0.00138	0.00752	CcSEcCtD
Aminoglutethimide—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.00138	0.0152	CbGpPWpGaD
Aminoglutethimide—Leukopenia—Temozolomide—brain cancer	0.00136	0.00741	CcSEcCtD
Aminoglutethimide—Dizziness—Procarbazine—brain cancer	0.00136	0.00739	CcSEcCtD
Aminoglutethimide—Myalgia—Carmustine—brain cancer	0.00134	0.00729	CcSEcCtD
Aminoglutethimide—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00133	0.0146	CbGpPWpGaD
Aminoglutethimide—Vomiting—Procarbazine—brain cancer	0.00131	0.0071	CcSEcCtD
Aminoglutethimide—Myalgia—Temozolomide—brain cancer	0.0013	0.00705	CcSEcCtD
Aminoglutethimide—Rash—Procarbazine—brain cancer	0.0013	0.00704	CcSEcCtD
Aminoglutethimide—Dermatitis—Procarbazine—brain cancer	0.0013	0.00704	CcSEcCtD
Aminoglutethimide—Headache—Procarbazine—brain cancer	0.00129	0.007	CcSEcCtD
Aminoglutethimide—CYP11A1—Biological oxidations—CYP2C9—brain cancer	0.00128	0.0141	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metapathway biotransformation—CYP2C9—brain cancer	0.00126	0.0139	CbGpPWpGaD
Aminoglutethimide—Body temperature increased—Hydroxyurea—brain cancer	0.00126	0.00684	CcSEcCtD
Aminoglutethimide—Tachycardia—Carmustine—brain cancer	0.00126	0.00682	CcSEcCtD
Aminoglutethimide—Anorexia—Carmustine—brain cancer	0.00123	0.00666	CcSEcCtD
Aminoglutethimide—Nausea—Procarbazine—brain cancer	0.00122	0.00664	CcSEcCtD
Aminoglutethimide—Hypotension—Carmustine—brain cancer	0.0012	0.00653	CcSEcCtD
Aminoglutethimide—Anorexia—Temozolomide—brain cancer	0.00119	0.00644	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Hydroxyurea—brain cancer	0.00117	0.00637	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Carmustine—brain cancer	0.00117	0.00637	CcSEcCtD
Aminoglutethimide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00117	0.0129	CbGpPWpGaD
Aminoglutethimide—Somnolence—Carmustine—brain cancer	0.00114	0.00621	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00113	0.00615	CcSEcCtD
Aminoglutethimide—Anaemia—Etoposide—brain cancer	0.00113	0.00612	CcSEcCtD
Aminoglutethimide—Decreased appetite—Carmustine—brain cancer	0.00112	0.00608	CcSEcCtD
Aminoglutethimide—Somnolence—Temozolomide—brain cancer	0.00111	0.00601	CcSEcCtD
Aminoglutethimide—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.0011	0.0122	CbGpPWpGaD
Aminoglutethimide—Leukopenia—Etoposide—brain cancer	0.00109	0.00593	CcSEcCtD
Aminoglutethimide—Decreased appetite—Temozolomide—brain cancer	0.00108	0.00587	CcSEcCtD
Aminoglutethimide—Dizziness—Hydroxyurea—brain cancer	0.00105	0.00572	CcSEcCtD
Aminoglutethimide—Body temperature increased—Carmustine—brain cancer	0.00102	0.00553	CcSEcCtD
Aminoglutethimide—Vomiting—Hydroxyurea—brain cancer	0.00101	0.0055	CcSEcCtD
Aminoglutethimide—Rash—Hydroxyurea—brain cancer	0.001	0.00545	CcSEcCtD
Aminoglutethimide—Dermatitis—Hydroxyurea—brain cancer	0.001	0.00545	CcSEcCtD
Aminoglutethimide—Headache—Hydroxyurea—brain cancer	0.000998	0.00542	CcSEcCtD
Aminoglutethimide—Urticaria—Temozolomide—brain cancer	0.000988	0.00537	CcSEcCtD
Aminoglutethimide—Body temperature increased—Temozolomide—brain cancer	0.000984	0.00534	CcSEcCtD
Aminoglutethimide—Tachycardia—Etoposide—brain cancer	0.000972	0.00528	CcSEcCtD
Aminoglutethimide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000954	0.0105	CbGpPWpGaD
Aminoglutethimide—Anorexia—Etoposide—brain cancer	0.000949	0.00515	CcSEcCtD
Aminoglutethimide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000949	0.0104	CbGpPWpGaD
Aminoglutethimide—Hypersensitivity—Carmustine—brain cancer	0.000949	0.00515	CcSEcCtD
Aminoglutethimide—Nausea—Hydroxyurea—brain cancer	0.000946	0.00514	CcSEcCtD
Aminoglutethimide—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000942	0.0104	CbGpPWpGaD
Aminoglutethimide—Hypotension—Etoposide—brain cancer	0.00093	0.00505	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Temozolomide—brain cancer	0.000917	0.00498	CcSEcCtD
Aminoglutethimide—CYP19A1—Ovarian Infertility Genes—CDK4—brain cancer	0.000916	0.0101	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000904	0.00995	CbGpPWpGaD
Aminoglutethimide—Somnolence—Etoposide—brain cancer	0.000885	0.00481	CcSEcCtD
Aminoglutethimide—Pruritus—Temozolomide—brain cancer	0.00088	0.00478	CcSEcCtD
Aminoglutethimide—Decreased appetite—Etoposide—brain cancer	0.000865	0.0047	CcSEcCtD
Aminoglutethimide—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00086	0.00947	CbGpPWpGaD
Aminoglutethimide—Dizziness—Carmustine—brain cancer	0.000851	0.00462	CcSEcCtD
Aminoglutethimide—CYP19A1—Biological oxidations—CYP2C9—brain cancer	0.000847	0.00932	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000835	0.00919	CbGpPWpGaD
Aminoglutethimide—Dizziness—Temozolomide—brain cancer	0.000823	0.00447	CcSEcCtD
Aminoglutethimide—Vomiting—Carmustine—brain cancer	0.000819	0.00444	CcSEcCtD
Aminoglutethimide—Rash—Carmustine—brain cancer	0.000812	0.00441	CcSEcCtD
Aminoglutethimide—Dermatitis—Carmustine—brain cancer	0.000811	0.0044	CcSEcCtD
Aminoglutethimide—Headache—Carmustine—brain cancer	0.000807	0.00438	CcSEcCtD
Aminoglutethimide—Vomiting—Temozolomide—brain cancer	0.000791	0.0043	CcSEcCtD
Aminoglutethimide—Urticaria—Etoposide—brain cancer	0.000791	0.00429	CcSEcCtD
Aminoglutethimide—Body temperature increased—Etoposide—brain cancer	0.000787	0.00427	CcSEcCtD
Aminoglutethimide—Rash—Temozolomide—brain cancer	0.000784	0.00426	CcSEcCtD
Aminoglutethimide—Dermatitis—Temozolomide—brain cancer	0.000784	0.00426	CcSEcCtD
Aminoglutethimide—Headache—Temozolomide—brain cancer	0.000779	0.00423	CcSEcCtD
Aminoglutethimide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000774	0.00851	CbGpPWpGaD
Aminoglutethimide—Nausea—Carmustine—brain cancer	0.000765	0.00415	CcSEcCtD
Aminoglutethimide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000744	0.00818	CbGpPWpGaD
Aminoglutethimide—Nausea—Temozolomide—brain cancer	0.000739	0.00401	CcSEcCtD
Aminoglutethimide—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000734	0.00808	CbGpPWpGaD
Aminoglutethimide—Hypersensitivity—Etoposide—brain cancer	0.000734	0.00398	CcSEcCtD
Aminoglutethimide—Pruritus—Etoposide—brain cancer	0.000704	0.00382	CcSEcCtD
Aminoglutethimide—Dizziness—Etoposide—brain cancer	0.000658	0.00357	CcSEcCtD
Aminoglutethimide—Vomiting—Etoposide—brain cancer	0.000633	0.00344	CcSEcCtD
Aminoglutethimide—Rash—Etoposide—brain cancer	0.000628	0.00341	CcSEcCtD
Aminoglutethimide—Dermatitis—Etoposide—brain cancer	0.000627	0.00341	CcSEcCtD
Aminoglutethimide—Headache—Etoposide—brain cancer	0.000624	0.00339	CcSEcCtD
Aminoglutethimide—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000603	0.00663	CbGpPWpGaD
Aminoglutethimide—Nausea—Etoposide—brain cancer	0.000591	0.00321	CcSEcCtD
Aminoglutethimide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000574	0.00632	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000566	0.00623	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000491	0.0054	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000487	0.00536	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000465	0.00512	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—RELA—brain cancer	0.000437	0.00481	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000432	0.00476	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000411	0.00452	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000405	0.00446	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000397	0.00437	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—IL2—brain cancer	0.000393	0.00433	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Corticotropin-releasing hormone—CTNNB1—brain cancer	0.00038	0.00418	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000359	0.00395	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000357	0.00393	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.00035	0.00385	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.00033	0.00363	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000325	0.00358	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.00032	0.00352	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000316	0.00348	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000265	0.00291	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000247	0.00272	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000244	0.00268	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000238	0.00262	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—CYP2C9—brain cancer	0.000219	0.00241	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000191	0.0021	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—BSG—brain cancer	0.000186	0.00205	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000172	0.00189	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000171	0.00188	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000169	0.00186	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—IDH1—brain cancer	0.00016	0.00176	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000158	0.00174	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000149	0.00164	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000146	0.0016	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CYP2C9—brain cancer	0.000145	0.00159	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000137	0.00151	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000134	0.00148	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000134	0.00148	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000131	0.00144	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000131	0.00144	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.00013	0.00143	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—ENO2—brain cancer	0.000126	0.00139	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—BSG—brain cancer	0.000123	0.00136	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000123	0.00135	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000115	0.00127	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Integrated Breast Cancer Pathway—TP53—brain cancer	0.000113	0.00124	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—IDH1—brain cancer	0.000106	0.00117	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	8.99e-05	0.000989	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.62e-05	0.000949	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—ENO2—brain cancer	8.37e-05	0.000921	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CYP2C9—brain cancer	7.03e-05	0.000773	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—BSG—brain cancer	5.98e-05	0.000658	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PIK3CG—brain cancer	5.8e-05	0.000638	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP2C9—brain cancer	5.48e-05	0.000603	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—IDH1—brain cancer	5.14e-05	0.000565	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—BSG—brain cancer	4.66e-05	0.000512	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP2C9—brain cancer	4.23e-05	0.000465	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.18e-05	0.00046	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—ENO2—brain cancer	4.06e-05	0.000447	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—IDH1—brain cancer	4e-05	0.000441	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PIK3CG—brain cancer	3.84e-05	0.000423	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—BSG—brain cancer	3.59e-05	0.000395	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.26e-05	0.000359	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ENO2—brain cancer	3.16e-05	0.000348	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—IDH1—brain cancer	3.09e-05	0.00034	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ENO2—brain cancer	2.44e-05	0.000269	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PIK3CG—brain cancer	1.86e-05	0.000205	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PIK3CG—brain cancer	1.45e-05	0.00016	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PIK3CG—brain cancer	1.12e-05	0.000123	CbGpPWpGaD
